A PHASE II STUDY OF CONTINUOUS INFUSION 5-FLUOROURACIL IN ADVANCED HOMRONEREFRACTORY PROSTATE CANCER : AN ILLINOIS CANCER CENTER STUDY. AUTHOR'S REPL Y